PMEF
IRWD icon

Point72 Middle East FZE’s Ironwood Pharmaceuticals IRWD Stock Holding History

Point72 Middle East FZE’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-42,902
Closed -$491K – 664
2023
Q4 		$491K Sell
42,902
-29,408
-41% -$291K 0.01% 828
2023
Q3 		$696K Buy
+72,310
New +$709K 0.02% 698
2023
Q2 		– Sell
-36,850
Closed -$388K – 1805
2023
Q1 		$388K Buy
+36,850
New +$413K 0.01% 754

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Point72 Middle East FZE's IRWD Position: Q1 2024 in Review

Point72 Middle East FZE sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2024, closing a stake of 42,902 shares — an estimated $491K sold.

Point72 Middle East FZE first reported a position in IRWD in Q1 2023 and held it in 3 quarters. The position peaked at $696K in Q3 2023. 261 funds tracked by Wall St. Rank hold IRWD as of Q1 2024.

  • Point72 Middle East FZE reported no remaining Ironwood Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 42,902 Ironwood Pharmaceuticals shares in Q1 2024, an estimated $491K.
  • Point72 Middle East FZE first reported a position in Ironwood Pharmaceuticals in Q1 2023 and held it in 3 quarters.
  • Point72 Middle East FZE's Ironwood Pharmaceuticals position peaked at $696K in Q3 2023.
  • 261 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.